vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and IMAX CORP (IMAX). Click either name above to swap in a different company.

IMAX CORP is the larger business by last-quarter revenue ($125.2M vs $93.1M, roughly 1.3× HIVE Digital Technologies Ltd.). IMAX CORP runs the higher net margin — 0.5% vs -98.1%, a 98.6% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 35.1%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 25.8%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.

HIVE vs IMAX — Head-to-Head

Bigger by revenue
IMAX
IMAX
1.3× larger
IMAX
$125.2M
$93.1M
HIVE
Growing faster (revenue YoY)
HIVE
HIVE
+183.4% gap
HIVE
218.6%
35.1%
IMAX
Higher net margin
IMAX
IMAX
98.6% more per $
IMAX
0.5%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
25.8%
IMAX

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
IMAX
IMAX
Revenue
$93.1M
$125.2M
Net Profit
$-91.3M
$637.0K
Gross Margin
-27.1%
57.6%
Operating Margin
19.3%
Net Margin
-98.1%
0.5%
Revenue YoY
218.6%
35.1%
Net Profit YoY
-234.0%
-88.0%
EPS (diluted)
$-0.38
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
IMAX
IMAX
Q4 25
$93.1M
$125.2M
Q3 25
$87.3M
$106.7M
Q2 25
$45.6M
$91.7M
Q1 25
$86.7M
Q4 24
$29.2M
$92.7M
Q3 24
$22.6M
$91.5M
Q2 24
$32.2M
$89.0M
Q1 24
$79.1M
Net Profit
HIVE
HIVE
IMAX
IMAX
Q4 25
$-91.3M
$637.0K
Q3 25
$-15.8M
$20.7M
Q2 25
$35.0M
$11.3M
Q1 25
$2.3M
Q4 24
$68.2M
$5.3M
Q3 24
$80.0K
$13.9M
Q2 24
$-18.3M
$3.6M
Q1 24
$3.3M
Gross Margin
HIVE
HIVE
IMAX
IMAX
Q4 25
-27.1%
57.6%
Q3 25
4.7%
63.1%
Q2 25
-13.6%
58.5%
Q1 25
61.4%
Q4 24
-43.7%
52.2%
Q3 24
-66.1%
55.8%
Q2 24
-7.4%
49.4%
Q1 24
59.3%
Operating Margin
HIVE
HIVE
IMAX
IMAX
Q4 25
19.3%
Q3 25
27.2%
Q2 25
15.6%
Q1 25
19.3%
Q4 24
10.3%
Q3 24
21.2%
Q2 24
3.2%
Q1 24
15.3%
Net Margin
HIVE
HIVE
IMAX
IMAX
Q4 25
-98.1%
0.5%
Q3 25
-18.1%
19.4%
Q2 25
76.8%
12.3%
Q1 25
2.7%
Q4 24
233.2%
5.7%
Q3 24
0.4%
15.2%
Q2 24
-56.7%
4.0%
Q1 24
4.1%
EPS (diluted)
HIVE
HIVE
IMAX
IMAX
Q4 25
$-0.38
$0.02
Q3 25
$-0.07
$0.37
Q2 25
$0.18
$0.20
Q1 25
$0.04
Q4 24
$0.52
$0.09
Q3 24
$0.00
$0.26
Q2 24
$-0.17
$0.07
Q1 24
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
IMAX
IMAX
Cash + ST InvestmentsLiquidity on hand
$151.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$337.9M
Total Assets
$624.0M
$894.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
IMAX
IMAX
Q4 25
$151.2M
Q3 25
$143.1M
Q2 25
$109.3M
Q1 25
$97.1M
Q4 24
$40.5M
$100.6M
Q3 24
$31.7M
$104.5M
Q2 24
$91.6M
Q1 24
$81.0M
Stockholders' Equity
HIVE
HIVE
IMAX
IMAX
Q4 25
$559.3M
$337.9M
Q3 25
$624.6M
$349.5M
Q2 25
$560.5M
$320.4M
Q1 25
$299.5M
Q4 24
$430.9M
$299.5M
Q3 24
$275.5M
$289.4M
Q2 24
$268.6M
$267.2M
Q1 24
$258.8M
Total Assets
HIVE
HIVE
IMAX
IMAX
Q4 25
$624.0M
$894.0M
Q3 25
$693.0M
$889.6M
Q2 25
$628.7M
$868.6M
Q1 25
$848.3M
Q4 24
$478.6M
$830.4M
Q3 24
$334.7M
$847.6M
Q2 24
$827.4M
Q1 24
$824.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
IMAX
IMAX
Operating Cash FlowLast quarter
$46.0M
$29.4M
Free Cash FlowOCF − Capex
$28.0M
FCF MarginFCF / Revenue
22.3%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
46.11×
TTM Free Cash FlowTrailing 4 quarters
$118.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
IMAX
IMAX
Q4 25
$46.0M
$29.4M
Q3 25
$-10.6M
$67.5M
Q2 25
$10.2M
$23.2M
Q1 25
$7.0M
Q4 24
$-28.5M
$11.5M
Q3 24
$-2.2M
$35.3M
Q2 24
$-4.4M
$35.0M
Q1 24
$-11.0M
Free Cash Flow
HIVE
HIVE
IMAX
IMAX
Q4 25
$28.0M
Q3 25
$64.8M
Q2 25
$20.9M
Q1 25
$5.3M
Q4 24
$-55.5M
$6.9M
Q3 24
$-34.7M
$34.2M
Q2 24
$33.5M
Q1 24
$-12.1M
FCF Margin
HIVE
HIVE
IMAX
IMAX
Q4 25
22.3%
Q3 25
60.7%
Q2 25
22.8%
Q1 25
6.1%
Q4 24
-189.9%
7.4%
Q3 24
-153.4%
37.3%
Q2 24
37.6%
Q1 24
-15.3%
Capex Intensity
HIVE
HIVE
IMAX
IMAX
Q4 25
1.1%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
1.9%
Q4 24
92.5%
5.0%
Q3 24
143.9%
1.2%
Q2 24
1.8%
Q1 24
1.4%
Cash Conversion
HIVE
HIVE
IMAX
IMAX
Q4 25
46.11×
Q3 25
3.27×
Q2 25
0.29×
2.06×
Q1 25
2.99×
Q4 24
-0.42×
2.16×
Q3 24
-26.94×
2.54×
Q2 24
9.78×
Q1 24
-3.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIVE
HIVE

Segment breakdown not available.

IMAX
IMAX

Technology Sales$46.6M37%
Image Enhancement And Maintenance Services$38.1M30%
Joint Revenue Sharing Arrangement$20.4M16%
Maintenance$16.3M13%
Finance Income$2.8M2%
Other Content Solutions$1.6M1%

Related Comparisons